| Website | nanobiotix.com |
| Category | BioTech |
| Phone | + 33 (0) 1 40 26 04 70 |
| Employees |
| TOTAL | $11M |
| VENTURE FUNDING TOTAL | $11M |
| Series C, 5/10 CIC Vizille Capital Innovation Masseran Gestion OTC Asset Management Amorçage Rhône Alpes | $11M |
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer. The company was incorporated in 2003 and is based in Paris, France.
